Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous […]
Glenmark Pharmaceuticals has launched Nourkrin Woman, a clinically-proven proteoglycan replacement formula, for normalising hair growth cycle. The product will be exclusively marketed in India by […]
Essentials Pharma is planning to set up a bulk drugs unit in Hirasar village in Rajkot district of Gujarat. The project involves setting up of […]
Genetics is the cause for dengue vulnerability of South and North East Asiana. While Africans are more immune to Dengue Shock Syndrome and other severe […]
Glenmark Pharmaceuticals has entered into an exclusive agreement with Sam Chun Dang Pharm (SCD) of South Korea to develop, manufacture and market a portfolio of […]
Jubilant Life Sciences has received final USFDA approval for Amantadine Hydrochloride tablets, an anti-viral and anti-Parkinsons drug. The drug is a generic version of Symmetrel […]
Morepen Laboratories has received USFDA approval for Montelukast Sodium, a bulk drug which is used in treatment of asthma and respiratory disorders. The drug market […]
Torrent plans has acquired the Bio-Pharm, Inc. (BPI) – a US-based generic pharmaceuticals and OTC company, The Bio-Pharm, Inc. (BPI). Was established in 1992 and […]
Panacea Biotec has signed an agreement with Serum Institute of India (SII) and its wholly owned subsidiary, Bilthovan Biologicals B.V. (BBIO). Under the agreement, SII […]
Glenmark Pharmaceuticals has launched the biosimilar drug Adalimumab in India. The drug will be marketed under a licensing agreement with Cadila Healthcare Ltd. It is […]
Copyright © 2024 | WordPress Theme by MH Themes